(-0.85%) 4 968.50 points
(0.50%) 37 965 points
(-2.00%) 15 290 points
(0.64%) $83.26
(0.17%) $1.760
(0.50%) $2 409.90
(1.60%) $28.84
(-1.23%) $942.80
(-0.06%) $0.939
(-0.17%) $11.02
(0.54%) $0.808
(-0.94%) $93.01
Live Chart Being Loaded With Signals
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide...
Stats | |
---|---|
Today's Volume | 845 893 |
Average Volume | 2.74M |
Market Cap | 10.09B |
EPS | $0 ( 2024-02-09 ) |
Next earnings date | ( $0.240 ) 2024-06-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.76 |
ATR14 | $0.0230 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Gunther Scott | Sell | 387 | Common Stock |
2024-01-25 | Kreuzburg Christa | Sell | 523 | Common Stock |
2024-01-16 | Hatzfeld Michael | Buy | 6 071 | Common Stock |
2024-01-16 | Hatzfeld Michael | Buy | 3 981 | Options to purchase Common Stock |
2024-01-16 | Hatzfeld Michael | Buy | 1 837 | Common Stock |
INSIDER POWER |
---|
71.16 |
Last 95 transactions |
Buy: 320 499 | Sell: 54 379 |
Volume Correlation
Catalent Inc Correlation
10 Most Positive Correlations | |
---|---|
HXL | 0.925 |
SSTK | 0.923 |
PNR | 0.912 |
HOV | 0.91 |
BWA | 0.91 |
BH | 0.907 |
GTES | 0.906 |
MWA | 0.906 |
ATI | 0.902 |
ESAB | 0.901 |
10 Most Negative Correlations | |
---|---|
JE | -0.922 |
CALX | -0.905 |
FSLF | -0.89 |
FAII | -0.874 |
EVTL | -0.867 |
JNJ | -0.865 |
AC | -0.863 |
AFI | -0.863 |
GRUB | -0.859 |
CHGG | -0.858 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Catalent Inc Correlation - Currency/Commodity
Catalent Inc Financials
Annual | 2023 |
Revenue: | $4.28B |
Gross Profit: | $1.06B (24.79 %) |
EPS: | $-1.280 |
Q4 | 2023 |
Revenue: | $1.07B |
Gross Profit: | $235.00M (22.00 %) |
EPS: | $-0.480 |
Q3 | 2023 |
Revenue: | $1.04B |
Gross Profit: | $180.00M (17.36 %) |
EPS: | $-1.250 |
Q2 | 2023 |
Revenue: | $1.15B |
Gross Profit: | $387.00M (33.68 %) |
EPS: | $0.450 |
Financial Reports:
No articles found.
Catalent Inc
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators